31 March 2023 - The outcome statement from the February 2023 DUSC meeting is now available.

The DUSC reviewed the utilisation of the following PBS listed medicines in February 2023:

• Evolocumab for hypercholesterolaemia
• Opioid receptor agonists for pain

Read DUSC outcome statement